Scarica l'app Stockscreener
6.04
0.66%
-0.04
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SLDB Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.08
Aprire:
$6.15
Volume 24 ore:
1.66M
Relative Volume:
1.00
Capitalizzazione di mercato:
$468.19M
Reddito:
$14.79M
Utile/perdita netta:
$-102.44M
Rapporto P/E:
-1.9868
EPS:
-3.04
Flusso di cassa netto:
$-91.73M
1 W Prestazione:
-9.85%
1M Prestazione:
+14.83%
6M Prestazione:
+71.10%
1 anno Prestazione:
-15.64%
Intervallo 1D:
$6.005
$6.3088
Intervallo di 1 settimana:
$5.75
$6.64
Portata 52W:
$2.41
$10.37
Solid Biosciences Inc Stock (SLDB) Company Profile
Nome
Solid Biosciences Inc
Settore
Industria
Telefono
617-337-4680
Indirizzo
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
Confronta SLDB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
6.04 | 471.29M | 14.79M | -102.44M | -91.73M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-26 | Iniziato | Citigroup | Buy |
| 2025-01-08 | Iniziato | Truist | Buy |
| 2024-12-13 | Iniziato | Wedbush | Outperform |
| 2024-12-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-07-15 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-06-24 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | Ripresa | Piper Sandler | Overweight |
| 2024-03-28 | Iniziato | William Blair | Outperform |
| 2024-03-15 | Iniziato | Citigroup | Buy |
| 2024-03-14 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-05-27 | Iniziato | Jefferies | Buy |
| 2021-03-16 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2021-01-08 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-10-11 | Iniziato | Evercore ISI | Outperform |
| 2019-08-29 | Downgrade | Citigroup | Neutral → Sell |
| 2019-08-19 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | Downgrade | Goldman | Neutral → Sell |
| 2019-02-08 | Aggiornamento | Citigroup | Sell → Neutral |
| 2019-02-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | Iniziato | Citigroup | Sell |
| 2018-09-06 | Iniziato | Credit Suisse | Neutral |
Mostra tutto
Solid Biosciences Inc Borsa (SLDB) Ultime notizie
Solid Biosciences Reports Increased Assets Amid Ongoing Losses - TipRanks
SOLID BIOSCIENCES Earnings Results: $SLDB Reports Quarterly Earnings - Quiver Quantitative
Solid Biosciences Pushes Forward Despite Growing Losses - Finimize
Solid Biosciences Q2 net loss widens to $39.5 mln - MarketScreener
Solid Biosciences Inc. Reports Progress in Clinical Trials and Financial Highlights for Q2 2025 - Quiver Quantitative
Solid Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire
How to read the order book for Solid Biosciences Inc.Market Forecast Summary Over Multi-Year Period - Newser
Smart tools for monitoring Solid Biosciences Inc.’s price actionDaily Swing Candidate Analysis with Chart Patterns - Newser
Applying big data sentiment scoring on Solid Biosciences Inc.Momentum Prediction Based on AI Backtesting - Newser
Risk adjusted return profile for Solid Biosciences Inc. analyzedStock Market Watch with Smart Filters - Newser
Solid Biosciences Inc. stock trend forecastFree Earnings Play Trade Plan With Alerts - Newser
Wyckoff Accumulation Phase Possible in Solid Biosciences Inc.Breakout Momentum Picks With Protection Outlined - beatles.ru
Key resistance and support levels for Solid Biosciences Inc.Volume Confirmed Setup with Entry Confidence - Newser
Solid Biosciences (SLDB) Projected to Post Quarterly Earnings on Tuesday - Defense World
Why Solid Biosciences Inc. stock attracts strong analyst attentionFree Weekly Potential Breakout Stock List - Newser
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of “Buy” from Analysts - Defense World
Solid Biosciences SLDB 2025Q2 Earnings Preview Upside Potential on Strategic Developments - AInvest
Will Solid Biosciences Inc. rebound enough to break evenPrice Movement and Market Sentiment Analysis - Newser
Applying Elliott Wave Theory to Solid Biosciences Inc.Chart Pattern Recognition for Profit Timing - Newser
Solid Biosciences Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView
How hedge fund analytics apply to Solid Biosciences Inc. stockSwing Entry Risk Mitigation with Chart Analysis - Newser
Allianz Asset Management GmbH Purchases Shares of 27,100 Solid Biosciences Inc. (NASDAQ:SLDB) - Defense World
Solid Biosciences Inc. shares rise 1.03% after-hours following Wall Street's recovery from jobs report-fueled losses. - AInvest
A Quick Look at Today's Ratings for Solid Biosciences(SLDB.US), With a Forecast Between $10 to $20 - 富途牛牛
What is the dividend policy of Solid Biosciences Inc. stockGet timely alerts on market opportunities - Jammu Links News
Should I hold or sell Solid Biosciences Inc. stock in 2025Discover stocks with massive upside potential - Jammu Links News
How strong is Solid Biosciences Inc. company’s balance sheetGet daily expert analysis for smarter investing - Jammu Links News
What are the latest earnings results for Solid Biosciences Inc.Robust investment performance - Jammu Links News
Is Solid Biosciences Inc. stock overvalued or undervaluedAchieve rapid returns with smart investment plans - Jammu Links News
What catalysts could drive Solid Biosciences Inc. stock higher in 2025Track top-performing stocks effortlessly - Jammu Links News
What drives Solid Biosciences Inc. stock priceConsistent double returns - Jammu Links News
Solid Biosciences Inc. Stock Analysis and ForecastIdentify undervalued stocks poised to rally - Jammu Links News
What makes Solid Biosciences Inc. stock price move sharplyBuild a diversified portfolio for risk management - Jammu Links News
What are Solid Biosciences Inc. company’s key revenue driversMaximize returns with data-driven strategies - Jammu Links News
When is Solid Biosciences Inc. stock expected to show significant growthDiscover undervalued stocks before they soar - Jammu Links News
What institutional investors are buying Solid Biosciences Inc. stockAchieve superior capital gains with smart trades - Jammu Links News
Solid Biosciences shares fall 2.78% after-hours following inducement grants announcement. - AInvest
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Solid Biosciences Strengthens Team with 55,450 RSU Grants for Key Genetic Medicine Experts - Stock Titan
Solid Biosciences reports inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Institutional Tools Highlight Unusual Flow in Solid Biosciences Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
What institutions are buying Solid Biosciences Inc. stock nowEarnings Play Trade Plan With Alerts Shared - metal.it
Technical Charts Suggest Momentum Shift in Solid Biosciences Inc.Oversold Recovery Opportunity Stocks Attract Buyers - metal.it
Solid Biosciences’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com
Solid Biosciences Inc. Approaches Support With Recovery in SightEntry Alert Based on Volume Spikes Detected - metal.it
Momentum Traders Eye Solid Biosciences Inc. for Quick BounceROI Boosting Trade Opportunity Calendar Published - metal.it
How volatile is Solid Biosciences Inc. stock compared to the marketMarket-leading profit generation - Jammu Links News
Solid Biosciences Inc Azioni (SLDB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):